Ticker Scorecard - JAZZ Basics Company: Jazz Pharmaceuticals plc IPO Date: June 1, 2007 Sector: Healthcare Industry: Biotech Market Cap: $7.48B Activated in VL: True Average Daily Range Avg Daily Range: $1.40 | 2.01% Avg Daily Range (30 D): $1.11 | 0.91% Avg Daily Range (90 D): $1.40 | 1.20% Institutional Daily Volume Avg Daily Volume: .57M Avg Daily Volume (30 D): .42M Avg Daily Volume (90 D): .47M Trade Size Avg Trade Size (Sh.): 87 Avg Trade Size (Sh.) (30 D): 39 Avg Trade Size (Sh.) (90 D): 43 Institutional Trades Total Inst.Trades: 9,180 Avg Inst. Trade: $4.45M Avg Inst. Trade (30 D): $6.34M Avg Inst. Trade (90 D): $4.83M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $7.37M Avg Closing Trade (30 D): $11.74M Avg Closing Trade (90 D): $11.25M Avg Closing Volume: 56.7K     News Nov 21, 2024 @ 11:00 AM FDA Grants U.S. Approval of Ziihera® (zanidatam... Source: Zymeworks Inc. Oct 29, 2024 @ 10:00 AM Zymeworks Announces Participation in Upcoming Inve... Source: N/A Oct 24, 2024 @ 11:00 AM VEON’s Jazz Launches FikrFree: An AI-Powere... Source: Veon Ltd. Oct 18, 2024 @ 9:21 AM Billionaire Seth Klarman Sold 64% of Baupost's Sta... Source: The Motley Fool Oct 1, 2024 @ 5:00 PM Breast Cancer Clinical Trial Pipeline Appears Robu... Source: Delveinsight Financials   TTM Q3 2024 Q2 2024 Basic EPS $7.45 $3.5 $2.68 Diluted EPS $7.2 $3.42 $2.49 Revenue $ 3.99B $ 1.05B $ 1.02B Gross Profit $ $ $ Net Income / Loss $ 463.16M $ 215.06M $ 168.57M Operating Income / Loss $ 648.36M $ 260.21M $ 199.44M Cost of Revenue $ $ $ Net Cash Flow $ 882.45M $ 862.33M $ -87.58M PE Ratio 16.83